
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Pharmacol. , 27 January 2021
Sec. Ethnopharmacology
Volume 11 - 2020 | https://doi.org/10.3389/fphar.2020.594847
This article is part of the Research Topic Integrative Pharmacology-based Research on Traditional Medicine: Methodologies, Medical and Pharmacological Applications View all 73 articles
A retraction of this article was approved in:
Retraction: Xianglian pill suppresses inflammation and protects intestinal epithelial barrier by promoting autophagy in DSS induced ulcerative colitis mice
Citation: Wang B, Gong Z, Zhan J, Yang L, Zhou Q and Yuan X (2021) Xianglian Pill Suppresses Inflammation and Protects Intestinal Epithelial Barrier by Promoting Autophagy in DSS Induced Ulcerative Colitis Mice. Front. Pharmacol. 11:594847. doi: 10.3389/fphar.2020.594847
Received: 14 August 2020; Accepted: 21 December 2020;
Published: 27 January 2021; Retracted: 08 September 2023.
Edited by:
Yanqiong Zhang, China Academy of Chinese Medical Sciences, ChinaReviewed by:
Wentzel Christoffel Gelderblom, Cape Peninsula University of Technology, South AfricaDisclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.